Table 1.
High risk versus low risk comparisons by study phase and units.
| Intervention Unit Patients | ||||
|---|---|---|---|---|
|
|
||||
| High Risk | Low Risk | |||
| Control Phase (n=54) | Experimental Phase (n=64) | Control Phase (n=122) | Experimental Phase (n=164) | |
|
|
||||
| Age (M, SD) | 66.13 (16.52) | 64.13 (15.75) | 59.66 (15.89) | 60.09 (14.77) |
| Race (%) | ||||
| White | 57.41 | 60.94 | 71.31 | 68.90 |
| Black | 25.93 | 29.69 | 17.21 | 18.29 |
| Gender (%) | ||||
| female | 51.85 | 40.63 | 39.34 | 33.54 |
| LOS (M, SD) | 8.09 (5.49) | 6.80 (5.69) | 3.61 (3.69) | 3.12 (2.70) |
| D2S2 score (M, SD) | 4.91 (1.20)a | 4.40 (0.90)a | 1.61 (0.86) | 1.60 (0.78) |
|
| ||||
| Non-intervention Unit Patients | ||||
|
|
||||
| High Risk | Low Risk | |||
| Control Phase (n=818) | Experimental Phase (n=923) | Control Phase (n=1822) | Experimental Phase (n=2299) | |
|
|
||||
| Age (M, SD) | 64.78 (16.81) | 65.72 (17.67) | 53.27 (16.33) | 53.85 (16.26) |
| Race (%) | ||||
| White | 46.09 | 48.00 | 55.71 | 55.72 |
| Black | 46.09 | 43.34 | 34.03 | 35.54 |
| Gender (%) | ||||
| female | 54.89 | 53.20 | 51.65 | 51.33 |
| LOS (M, SD) | 7.15 (6.48)a | 5.21 (4.06)a | 4.20 (3.91)b | 3.74 (3.24)b |
| D2S2 score (M, SD) | 4.57 (1.12) | 4.45 (0.97) | 1.63 (0.84) | 1.63 (0.84) |
a
p-value <0.001
b
p-value <0.05
Length of Stay (LOS)